Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-03-31Clinical Trial Update: CNI Transient Replacement by Belatacept From 3 to 12 Months Post Transplantation in Patients With Early Graft Dysfunction [Phase 3]
A Phase 3 clinical trial update exploring belatacept as a transient replacement for calcineurin inhibitors from 3 to 12 months after transpl…
-
CLINICAL_TRIALS trial_result · 2020-03-24Clinical Trial Update: Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency [NA]
A completed clinical trial comparing ferric citrate to ferrous sulfate for iron parameters and hemoglobin in chronic kidney disease patients…
-
CLINICAL_TRIALS trial_result · 2020-03-18Clinical Trial Update: Care Coordination/Home Telehealth to Safeguard Care in CKD [NA]
A completed clinical trial evaluating care coordination and home telehealth to safeguard care in chronic kidney disease; results posted in 2…
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: Chlortalidone and Bumetanide in Advanced Chronic Kidney Disease: HEBE-CKD Trial [Phase 2]
Phase 2 trial evaluating chlortalidone and bumetanide in advanced chronic kidney disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-06Clinical Trial Update: Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease [Phase 3]
Phase 3 trial comparing iron isomaltoside/ferric derisomaltose to iron sucrose for iron deficiency anemia in non-dialysis-dependent chronic …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-03-03Clinical Trial Update: A Study of RBT-3 in Healthy Volunteers and Volunteers With Stage 3/4 Chronic Kidney Disease [Phase 1]
Phase 1 study of RBT-3 in healthy volunteers and patients with chronic kidney disease has completed. Results have been posted.
-
FDA approval · 2020-02-28FDA Approved: VELPHORO — Supplemental Application (Fresenius Medical Care Renal Therapies Group, LLC)
The FDA approved a supplemental application for Velphoro (sucroferric oxyhydroxide) submitted by Fresenius Medical Care Renal Therapies Grou…
-
CLINICAL_TRIALS trial_result · 2020-02-26Clinical Trial Update: Preemptive Treatment With Grazoprevir and Elbasvir for Donor HCV Positive to Recipient HCV Negative Kidney Transplant [Phase 4]
A Phase 4 clinical trial updated results on preemptive Grazoprevir/Elbasvir treatment for donor HCV positive to recipient HCV negative kidne…
-
CLINICAL_TRIALS trial_result · 2020-02-24Clinical Trial Update: Ascorbic Acid Administration in the Treatment of Anemia in Chronic Hemodialysed Patients [Phase 4]
Phase 4 clinical trial assessing ascorbic acid administration for anemia in chronic hemodialysis patients.
-
FDA approval · 2020-02-21FDA Approved: CALCIUM ACETATE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original application for calcium acetate capsules (667 mg) from Rising Pharma Holdings, Inc., a generic product.
-
CLINICAL_TRIALS trial_result · 2020-02-20Clinical Trial Update: A Study to Test Whether ZS (Sodium Zirconium Cyclosilicate) Can Reduce the Incidence of Increased Blood Potassium Levels Among Dialized Patients. [Phase 3]
Phase 3 trial assessing whether ZS (Sodium Zirconium Cyclosilicate) reduces episodes of high potassium in dialyzed patients with hyperkalemi…
-
CLINICAL_TRIALS withdrawal · 2020-02-17Clinical Trial Update: Treatment of Asymptomatic Fluid Overload in Peritoneal Dialysis Patients [Phase 4]
A Phase 4 clinical trial investigating treatment of asymptomatic fluid overload in peritoneal dialysis patients has been withdrawn.
-
FDA approval · 2020-02-07FDA Approved: DOXERCALCIFEROL — Original Application (Meitheal Pharmaceuticals Inc.)
FDA approves the original ANDA for doxercalciferol, a generic vitamin D analog from Meitheal Pharmaceuticals, for the treatment of secondary…
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Study of the Safety, Tolerability, and Pharmacokinetics of LHW090 in Patients With Moderately Impaired Renal Function [Phase 2]
Phase 2 clinical trial evaluating safety, tolerability, and pharmacokinetics of LHW090 in patients with moderately impaired renal function h…
-
CLINICAL_TRIALS trial_result · 2020-01-28Clinical Trial Update: Switching From Tenofovir Disoproxil Fumarate to Abacavir or Tenofovir Alafenamide [Phase 4]
Phase 4 trial update evaluating switching from tenofovir disoproxil fumarate to abacavir or tenofovir alafenamide in individuals with chroni…
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease [Phase 2]
Phase 2 trial evaluating spironolactone in combination with patiromer for resistant hypertension in chronic kidney disease; results posted i…
-
CLINICAL_TRIALS trial_result · 2020-01-14Clinical Trial Update: Evaluation of TRC101 in Subjects With Chronic Kidney Disease and Metabolic Acidosis [Phase 1, Phase 2]
A study updating on TRC101 in chronic kidney disease patients with metabolic acidosis in Phase 1/2; results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-09Clinical Trial Update: Effect of Harvoni on Proteinuria and eGFR in Hepatitis C Virus Associated Chronic Kidney Disease (CKD) [NA]
A terminated clinical trial assessing the effect of Harvoni on proteinuria and eGFR in patients with hepatitis C–associated chronic kidney d…
-
CLINICAL_TRIALS trial_result · 2020-01-07Clinical Trial Update: Alkali Therapy in Chronic Kidney Disease [Phase 2, Phase 3]
Phase 2/3 clinical trial update on alkali therapy for chronic kidney disease with metabolic acidosis; trial completed and results posted in …
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: everlinQ Endovascular Access Systems Enhancements (EASE-2) Study [NA]
This clinical trial update reports on the EASE-2 study evaluating enhancements to the everlinQ Endovascular Access System; results were post…
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: A Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Investigate and Compare the Efficacy, Safety and Tolerability of Lanthanum Carbonate With Calcium Carbonate in Hyperphosphataemic Children and Adolescents With Chronic Kidney Disease on Dialysis [Phase 2]
Phase 2 trial assessing pharmacokinetics and comparing lanthanum carbonate to calcium carbonate for efficacy and safety in hyperphosphatemic…
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: A Study to Explore the Renal Safety of Visipaque Injection 320 mgI/mL in Patients With Chronic Kidney Disease [Phase 4]
Phase 4 trial update investigating the renal safety of Visipaque Injection 320 mgI/mL in patients with chronic kidney disease; study termina…
-
CLINICAL_TRIALS trial_result · 2019-12-16Clinical Trial Update: Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease, on Dialysis. [Phase 3]
Phase 3 trial update for roxadustat in treating anemia in patients with chronic kidney disease on dialysis; study completed with posted resu…
-
CLINICAL_TRIALS trial_result · 2019-12-16Clinical Trial Update: Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis [Phase 3]
Phase 3 clinical trial on Roxadustat for anemia in chronic kidney disease patients not on dialysis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: Peer-mentoring, Quality of Life and Caregiver Burden in Patients With Chronic Kidney Disease and Their Caregivers [NA]
A completed clinical trial evaluating peer-mentoring, quality of life, and caregiver burden in patients with chronic kidney disease and thei…